Evidence supporting a role for dormant bacteria in the pathogenesis of spondylarthritis

Joint Bone Spine

Volumn 80, Issue 2, 2013, Pages 135-140

  Berthelot, Jean Marie ^a   de la Cochetière, Marie France ^b   Potel, Gilles ^b   Le Goff, Benoît ^a   Maugars, Yves ^a  

^a HÔTEL DIEU   (France)

^b UNIVERSITÉ DE NANTES   (France)

Author keywords

Ankylosing spondylitis; Bacteria; Crohn's disease; Dormancy; Dormant; HLA B27; Latent; Persistent; Regulon; SAPHO syndrome; Spondylarthropathy

Indexed keywords

ANTIBIOTIC AGENT; HLA B27 ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

BACTERIUM; BACTERIUM CULTURE; CELL STRESS; CHLAMYDIA; ENTEROBACTERIACEAE; HUMAN; METASTASIS; MYCOBACTERIUM TUBERCULOSIS; MYCOPLASMA; NONHUMAN; PATHOGENESIS; PROTEIN FOLDING; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SHORT SURVEY; SPONDYLARTHRITIS; SPONDYLITIS;

BACTERIA; BACTERIAL INFECTIONS; EVIDENCE-BASED MEDICINE; HUMANS; SPONDYLARTHRITIS;

EID: 84875541682     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2012.08.002     Document Type: Short Survey

References (60)

1. Antibus D.E., Leff L.G., Hall B.L., et al. Cultivable bacteria from ancient algal mats from the McMurdo Dry Valleys, Antarctica. Extremophiles 2012, 16:105-114.
2. Hayes C.S., Low D.A. Signals of growth regulation in bacteria. Curr Opin Microbiol 2009, 12:667-673.
3. Segev E., Smith Y., Ben-Yehuda S. RNA dynamics in aging bacterial spores. Cell 2012, 148:139-149.
4. Abomoelak B., Marcus S.A., Ward S.K., et al. Characterization of a novel heat shock protein (Hsp22.5) involved in the pathogenesis of Mycobacterium tuberculosis. J Bacteriol 2011, 193:3497-3505.
5. Degde S.R., Rajasingh H., Das C., et al. Understanding communication signals during mycobacterial latency through predicted genome-wide protein interactions and Boolean modeling. PLoS One 2012, 7:e33893.
6. Gerasimova A., Kazakov A.E., Arkin A.P., et al. Comparative genomics of the dormancy regulons in mycobacteria. J Bacteriol 2011, 193:3446-3452.
7. Cerca F., Andrade F., Franca A., et al. Staphylococcus epidermidis biofilms with higher proportions of dormant bacteria induce a lower activation of murine macrophages. J Med Microbiol 2011, 60:1717-1724.
8. Jayaraman R. Bacterial persistence. New insights into an old phenomenon. J Biosci 2008, 33:795-805.
9. Avati B.P. Microbial dormancy in batch cultures as a function of substrate-dependent mortality. J Theor Biol 2012, 293:34-40.
10. Ge S., He Q., Granfors K. HLA-B27 modulates intracellular growth of Salmonella pathogenicity island 2 mutants and production of cytokines in infected monocytic U937 cells. PLoS One 2012, 7:e34093.
11. Sachidanandham R., Yew-Hoong Gin K. A dormancy state in nonspore-forming bacteria. Appl Microbiol Biotechnol 2009, 81:927-941.
12. Ohlsen K., Dandekar G., Schwarz R., et al. New trends in pharmacogenomic strategies against resistance development in microbial infections. Pharmacogenomics 2008, 9:1711-1723.
13. Chao M.C., Rubin E.J. Letting sleeping dos lie: does dormancy play a role in tuberculosis?. Annu Rev Microbiol 2010, 64:293-311.
14. Neyrolles O., Hernandez-Pando R., Pietri-Rouxel F., et al. Is adipose tissue a place for Mycobacterium tuberculosis persistence?. PLoS One 2006, 1:e43.
15. Marolvits S., Khanakah G., Striessnig G., et al. Emergence of Lyme arthritis after autologous chondrocyte transplantation. Arthritis Rheum 2004, 50:259-264.
16. Mutschler H., Meinhart A. e{open}/ζ systems: their role in resistance, virulence, and their potential for antibiotic development. J Mol Med 2011, 89:1183-1194.
17. Maisonneuve E., Shakespeare L.J., Jorgensen M.G., et al. Bacterial persistence by RNA endonucleases. Proc Natl Acad Sci U S A 2011, 108:13206-13211.
18. Tashiro Y., Kawata K., Taniuchi A., et al. RelE-mediated dormancy is enhanced at high cell density in Escherichia coli. J Bacteriol 2012, 194:1169-1176.
19. Martinez J.L., Rojo F. Metabolic regulation of antibiotic resistance. FEMS Microbiol Rev 2011, 35:768-789.
20. Buerger S., Spoering A., Gavrish E., et al. Microbial scout hypothesis and microbial discovery. Appl Environ Microbiol 2012, 78:3229-3233.
21. Dworkin J., Shah I.M. Exit from dormancy in microbial organisms. Nat Rev Microbiol 2010, 8:890-896.
22. Bragado P., Sosa M.S., Keely P., et al. Microenvironments dictating tumor cell dormancy. Recent Results Cancer Res 2012, 195:25-39.
23. Kobaysahi A., Okuda H., Xing F., et al. Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone. J Exp Med 2011, 208:2641-2655.
24. Wilson A., Laurenti E., Trumpp A. Balancing dormant and self-renewing hematopoietic stem cells. Curr Opin Genet Dev 2009, 19:461-468.
25. Arai F., Suda T. Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche. Ann N Y Acad Sci 2007, 1106:41-53.
26. Ehninger A., Trumpp A. The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J Exp Med 2011, 208:421-428.
27. Takaishi H., Shiono Y., Matsumoto M. Updates on ossification of posterior longitudinal ligament. Bone metabolism in ossification of posterior longitudinal ligament. Clin Calcium 2009, 19:1442-1447.
28. Colina M., Lo Monaco A., Khodeir M., et al. Propionibacterium acnes and SAPHO syndrome: a case report and literature review. Clin Exp Rheumatol 2007, 25:457-460.
29. Assmann G., Kueck O., Kirchhoff T., et al. Efficacy of antibiotic therapy for SAPHO syndrome is lost after its discontinuation: an interventional study. Arthritis Res Ther 2009, 11:R140.
30. Marakova K.S., Grishin N.V., Koovin E.V. The HicAB cassette, a putative novel, RNA-targeting toxin-antitoxin system in archaea and bacteria. Bioinformatics 2006, 22:2581-2584.
31. Breban M., Hacquard-Bouder C., Falgarone G. Animal models of HLA-B27-associated diseases. Curr Mol Med 2004, 4:31-40.
32. Sinkorova Z., Capkova J., Niederlova J., et al. Commensal intestinal bacterial strains trigger ankylosing enthesopathy of the ankle in inbred B10.BR (H-2(k)) male mice. Hum Immunol 2008, 69:845-850.
33. Cocchiaro J.L., Valdivia R.H. New insights into Chlamydia intracellular survival mechanisms. Cell Microbiol 2009, 11:1571-1578.
34. Wolf K., Betts K.J., Chellas-Géry B., et al. Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle. Mol Microbiol 2006, 61:1543-1555.
35. Carter J.D., Gérard H.C., Espinoza L.R., et al. Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis Rheum 2009, 60:1311-1316.
36. Dlugosz A., Törnblom H., Mohammadian G., et al. Chlamydia trachomatis antigens in enteroendocrine cells and macrophages of the small bowel in patients with severe irritable bowel syndrome. BMC Gastroenterol 2010, 10:19.
37. Pena A.S., Karimi O., Crusius J.B. A new avenue to investigate: the autophagic process. From Crohn's disease to Chlamydia. Drugs Today (Barc) 2009, 45:113-117.
38. Deng X., Li Z., Zhang W. Transcriptome sequencing of Salmonella enterica serovar Enteritidis under desiccation and starvation stress in peanut oil. Food Microbiol 2012, 30:311-315.
39. Helaine S., Thompson J.A., Watson K.G., et al. Dynamics of intracellular bacterial replication at the single cell level. Proc Natl Acad Sci U S A 2010, 107:3746-3751.
40. Nicolo M.S., Gioffrè A., Carnazza S., et al. Viable but nonculturable state of foodborne pathogens in grapefruit juice: a study of laboratory. Foodborne Pathog Dis 2011, 8:11-17.
41. Mitchell R.J., Lee S.K., Kim T., et al. Microbial linguistics: perspectives and applications of microbial cell-to-cell communication. BMB Rep 2011, 44:1-10.
42. Lee Y.K., Mazmanian S.K. Has the microbiota played a critical role in the evolution of the adaptive immune system?. Science 2010, 330:1768-1773.
43. Kuwahara T., Ogura Y., Oshima K., et al. The lifestyle of the segmented filamentous bacterium: a non-culturable gut-associated immunostimulating microbe inferred by whole-genome sequencing. DNA Res 2011, 18:291-303.
44. Fava F., Danese S. Intestinal microbiota in inflammatory bowel disease: friend or foe?. World J Gastroenterol 2011, 17:557-566.
45. Chassaing B., Rolhion N., de Vallée A., et al. Crohn disease-associated adherent-invasive E. coli bacteria target mouse and human Peyer's patches via long polar fimbriae. J Clin Invest 2011, 121:966-975.
46. Yamaguchi Y., Inouye M. Regulation of growth and death in Escherichia coli by toxin-antitoxin systems. Nat Rev Microbiol 2011, 9:779-790.
47. Lapaquette P., Bringer M.A., Darfeuille-Michaud A., et al. Defects in autophagy favour adherent-invasive Escherichia coli persistence within macrophages leading to increased pro-inflammatory response. Cell Microbiol 2012, 14:791-807.
48. De Vos M. Joint involvement associated with inflammatory bowel disease. Dig Dis 2009, 27:511-545.
49. Ciccia F., Bombardieri M., Principato A., et al. Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis Rheum 2009, 60:955-965.
50. Stebbings S., Munro K., Simon M.A., et al. Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis. Rheumatology (Oxford) 2002, 41:1395-1401.
51. Vaahtovuo J., Munukka E., Korkeamäki M., et al. Fecal microbiota in early rheumatoid arthritis. J Rheumatol 2008, 35:1500-1505.
52. Dorofeyev A.E., Vasilenko I.V., Rassokhina O.A. Joint extraintestinal manifestations in ulcerative colitis. Dig Dis 2009, 27:502-510.
53. Rehman A., Lepage P., Nolte A., et al. Transcriptional activity of the dominant gut mucosal microbiota in chronic inflammatory bowel disease patients. J Med Microbiol 2010, 59:1114-1122.
54. Njau F., Wittkop U., Rohde M., et al. In vitro neutralization of tumor necrosis factor-alpha during Chlamydia pneumoniae infection impairs dendritic cells maturation/function and increases chlamydial progeny. FEMS Immunol Med Microbiol 2009, 55:215-225.
55. Van Diepen A., Martina C.A., Flierman R., et al. Treatment with anti-TNF alpha does not induce reactivation of latent Salmonella enterica serovar Typhimurium infection in C3H/HeN mice. Scand J Immunol 2007, 65:407-411.
56. Meyer A., Chatelus E., Wendling D., et al. Safety and efficacy of anti-tumor necrosis factor α therapy in ten patients with recent-onset refractory reactive arthritis. Arthritis Rheum 2011, 63:1274-1280.
57. Demina G.R., Makarov V.A., Nikitushkin V.D., et al. Finding of the low molecular weight inhibitors of resuscitation promoting factor enzymatic and resuscitation activity. PLoS One 2009, 4:e8174.
58. Kim J.S., Heo P., Yang T.J., et al. Selective killing of bacterial persisters by a single chemical compound without affecting normal antibiotic-sensitive cells. Antimicrob Agents Chemother 2011, 55:5380-5383.
59. Kana B.D., Mizrahi V. Resuscitation-promoting factors as lytic enzymes for bacterial growth and signaling. FEMS Immunol Med Microbiol 2010, 58:39-50.
60. Aydin I., Saijo-Hamano Y., Namba K., et al. Structural analysis of the essential resuscitation promoting factor YeaZ suggests a mechanism of nucleotide regulation through dimer reorganization. PLoS One 2011, 6:e23245.